Hem › Geografisk atrofi › Michigan
Kliniska studier för Geografisk atrofi i Michigan
5 studier för Geografisk atrofi söker deltagare vid platser i Michigan.
Officiell studietext (engelska)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Foundation for Vision Research, Grand Rapids
RekryterarFas 2/3
Ålder 60 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06635148A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Associates of Michigan, Grand Blanc
RekryterarFas 3
Ålder 50 till 85 · Alla kön · Uppdaterad 18 sep. 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- University of Michigan Kellogg Eye Center, Ann Arbor
- Associated Retinal Consultants, P.C., Royal Oak
- Associated Retinal Consultants, P.C., Traverse City
RekryterarFas 2
Ålder 55 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University of Michigan Kellog Eye Center, Ann Arbor
RekryterarFas 1
Ålder 50 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT03178149Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Oakland Ophthalmic Surgery, Birmingham
Rekryterar
Ålder 65 och äldre · Alla kön · Uppdaterad 3 dec. 2024 · NCT05438732Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.